| 2025 | 2024 | 2024 | 2023 | 2022 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 1,3 M € | +32.7% | 953,3 k € | -62.6% | 2,5 M € | +12.3% | 2,3 M € | +25.0% | 1,8 M € | +45.1% | 1,2 M € | +73.2% | 721,1 k € | -70.6% | 2,5 M € | +68.5% | 1,5 M € | +27.2% | 1,1 M € | +28.5% | 891,2 k € | +13.0% | 788,6 k € | +43.6% | 549,3 k € | +12.9% | 486,4 k € | +16.5% | 417,4 k € | -9.0% | 458,7 k € | -32.0% | 674,3 k € | -20.3% | 845,7 k € | |
| EBITDA | 945,1 k € | +12.9% | 837,0 k € | -64.5% | 2,4 M € | +12.5% | 2,1 M € | +26.0% | 1,7 M € | +52.1% | 1,1 M € | +103.5% | 537,5 k € | -76.1% | 2,3 M € | +76.4% | 1,3 M € | +44.4% | 884,2 k € | +31.3% | 673,7 k € | +17.6% | 572,6 k € | +74.6% | 328,0 k € | +12.3% | 292,2 k € | +29.2% | 226,1 k € | -14.4% | 264,3 k € | -48.4% | 512,6 k € | -26.6% | 698,6 k € | |
| Operating profit | 938,0 k € | +12.1% | 836,8 k € | -67.5% | 2,6 M € | +43.2% | 1,8 M € | +12.9% | 1,6 M € | +54.2% | 1,0 M € | +112.5% | 485,7 k € | -77.9% | 2,2 M € | +71.7% | 1,3 M € | +62.2% | 789,6 k € | +26.2% | 625,5 k € | +18.2% | 529,3 k € | +82.6% | 289,8 k € | +15.6% | 250,8 k € | +48.1% | 169,4 k € | -25.6% | 227,8 k € | -51.4% | 468,4 k € | -28.5% | 655,1 k € | |
| Profit/loss | 703,9 k € | +9.8% | 641,1 k € | -71.4% | 2,2 M € | +55.7% | 1,4 M € | +10.3% | 1,3 M € | +54.2% | 848,0 k € | +101.2% | 421,4 k € | -87.8% | 3,5 M € | +114.0% | 1,6 M € | +254.2% | 456,6 k € | +158.4% | 176,7 k € | +589.6% | -36,1 k € | -110.7% | 337,9 k € | +2.4% | 330,0 k € | +33.3% | 247,5 k € | -17.1% | 298,5 k € | -10.9% | 335,2 k € | -21.3% | 425,6 k € | |
| Equity | 1,9 M € | -5.7% | 2,1 M € | -80.9% | 10,8 M € | +19.2% | 9,1 M € | +15.8% | 7,9 M € | -10.1% | 8,7 M € | +6.7% | 8,2 M € | +3.8% | 7,9 M € | +78.0% | 4,4 M € | +57.4% | 2,8 M € | +12.2% | 2,5 M € | +3.1% | 2,4 M € | -55.0% | 5,4 M € | +6.7% | 5,1 M € | +5.3% | 4,8 M € | +4.7% | 4,6 M € | +6.9% | 4,3 M € | +8.4% | 4,0 M € | |
| Total assets | 5,4 M € | +19.2% | 4,5 M € | -61.7% | 11,9 M € | +19.4% | 10,0 M € | +8.3% | 9,2 M € | -5.4% | 9,7 M € | +3.0% | 9,4 M € | +6.2% | 8,9 M € | +52.3% | 5,8 M € | +14.8% | 5,1 M € | -15.5% | 6,0 M € | -15.1% | 7,1 M € | -23.6% | 9,3 M € | +1.1% | 9,2 M € | +5.9% | 8,6 M € | +12.8% | 7,7 M € | +1.0% | 7,6 M € | +6.3% | 7,1 M € | |
| Cash | 408,6 k € | -70.8% | 1,4 M € | +200.1% | 466,6 k € | -31.2% | 678,6 k € | -78.3% | 3,1 M € | -33.3% | 4,7 M € | +18.1% | 4,0 M € | +32.6% | 3,0 M € | +150.3% | 1,2 M € | +207.8% | 388,5 k € | +227.5% | 118,6 k € | -87.1% | 920,0 k € | -28.9% | 1,3 M € | +3420.1% | 36,8 k € | -70.1% | 122,8 k € | +216.0% | 38,9 k € | +10.6% | 35,2 k € | -59.7% | 87,3 k € | |
| Debts | 3,5 M € | +39.9% | 2,5 M € | +145.3% | 1,0 M € | +19.2% | 847,0 k € | -36.1% | 1,3 M € | +37.4% | 964,4 k € | -20.2% | 1,2 M € | +23.6% | 977,3 k € | -29.7% | 1,4 M € | -37.4% | 2,2 M € | -36.3% | 3,5 M € | -24.5% | 4,6 M € | +21.1% | 3,8 M € | -6.3% | 4,1 M € | +7.1% | 3,8 M € | +24.5% | 3,1 M € | -6.9% | 3,3 M € | +3.7% | 3,2 M € | |
| Staff | 5,4 | 4 | 2,9 | 2,8 | 2,7 | 3,4 | 3,6 | 4 | 3,9 | 3,9 | 3,7 | 3,6 | 3,5 | 3,8 | 3,5 | 3,1 | 3,8 | 3,9 | ||||||||||||||||||
Public limited company · Oostkamp · incorporated on 30/08/1984 · 5,4 ETP
Public limited company profitable and well capitalised. Cash position declining (-70.8%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
WAAROOST is a Public limited company incorporated in 1984. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Oostkamp. It employs on average 5,4 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette